Consumption of new psychoactive substances in a Spanish sample of research chemical users

被引:30
作者
Gonzalez, Debora [1 ,2 ,3 ,4 ]
Ventura, Mireia [5 ]
Caudevilla, Fernando [6 ]
Torrens, Marta [1 ,2 ,3 ,4 ]
Farre, Magi [1 ,2 ,3 ,4 ]
机构
[1] Hosp del Mar, INAD, Med Res Inst, Human Pharmacol & Clin Neurosci Unit,IMIM, Barcelona, Spain
[2] Hosp del Mar, INAD, Med Res Inst, Drug Addict Unit,IMIM, Barcelona, Spain
[3] Univ Autonoma Barcelona, Dept Pharmacol, E-08193 Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Psychiat, E-08193 Barcelona, Spain
[5] Asociac Bienestar & Desarrollo, Barcelona, Spain
[6] SEMFYC, Ctr Salud Puerta Bonita I, Grp Intervenc Drogas, Area 11, Madrid, Spain
关键词
research chemicals; 2C-B; consumption patterns; new psychoactive substances; RECREATIONAL DRUGS; MEPHEDRONE USE; LEGAL HIGHS; TRENDS; MARKET; PATTERNS; PEOPLE; KID; WEB;
D O I
10.1002/hup.2323
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To know the pattern of use of new psychoactive substances (NPSs) in a Spanish sample of research chemical (RC) users and to deepen the RC user profile and risk reduction strategies employed. Methods This study is a cross-sectional survey by means of a specific questionnaire. Recruitment was carried out at music festivals, at non-governmental organizations (NGOs), and through announcements on an online forum. Two RC user profiles were defined, according to whether they search information through online forums. Results A total of 230 users participated. The most frequent RCs were hallucinogenic phenethylamines (2C-B 80.0%, 2C-I 39.6%) and cathinones (methylone 40.1%, mephedrone 35.2%). The most frequent combination of RC with other illegal drugs was with cannabis (68.6%) and 2C-B with MDMA (28.3%). Subjects who are consulting drug forums (group 1) use more RC, obtain RC by Internet, and use more frequently risk prevention strategies. Regarding the risk-reduction strategies in this group, users sought information concerning RC before consuming them (100%), used precision scales to calculate dosage (72.3%), and analyzed the contents before consumption (68.8%). Conclusions There is a specific RC user profile with extensive knowledge and consumption of substances, using different strategies to reduce risks associated to its consumption. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:332 / 340
页数:9
相关论文
共 42 条
[1]  
ACMD, 2010, REP CONS CATH
[2]  
[Anonymous], 2010, ANN REP STAT DRUGS P
[3]  
[Anonymous], 2012, EUR MON CTR DRUGS DR
[4]   Reference materials for new psychoactive substances [J].
Archer, Roland P. ;
Treble, Ric ;
Williams, Keith .
DRUG TESTING AND ANALYSIS, 2011, 3 (7-8) :505-514
[5]   A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill) health. Legal highs or illegal highs? [J].
Ayres, Tammy C. ;
Bond, John W. .
BMJ OPEN, 2012, 2 (04)
[6]   An analysis of legal highs - do they contain what it says on the tin? [J].
Baron, Mark ;
Elie, Mathieu ;
Elie, Leonie .
DRUG TESTING AND ANALYSIS, 2011, 3 (09) :576-581
[7]   Emerging psychoactive substance use among regular ecstasy users in Australia [J].
Bruno, Raimondo ;
Matthews, Allison J. ;
Dunn, Matthew ;
Alati, Rosa ;
Mcllwraith, Fairlie ;
Hickey, Sophie ;
Burns, Lucy ;
Sindicich, Natasha .
DRUG AND ALCOHOL DEPENDENCE, 2012, 124 (1-2) :19-25
[8]   Instability of the ecstasy market and a new kid on the block: mephedrone [J].
Brunt, Tibor M. ;
Poortman, Anneke ;
Niesink, Raymond J. M. ;
van den Brink, Wim .
JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (11) :1543-1547
[9]   Internet surveillance: Content analysis and monitoring of product-specific Internet prescription opioid abuse-related postings [J].
Butler, Stephen F. ;
Venuti, Synne Wing ;
Benoit, Christine ;
Beaulaurier, Richard L. ;
Houle, Brian ;
Katz, Nathaniel .
CLINICAL JOURNAL OF PAIN, 2007, 23 (07) :619-628
[10]   4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects [J].
Caudevilla-Galligo, Fernando ;
Riba, Jordi ;
Ventura, Mireia ;
Gonzalez, Debora ;
Farre, Magi ;
Barbanoj, Manel J. ;
Carlos Bouso, Jose .
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (07) :1026-1035